Nerve, autonomic and ultrasound checks for nerve damage in people with diabetes
Tests combined nerve, autonomic and ultrasound assessments in adults with diabetic peripheral neuropathy.
Key facts
- Who runs it
- Assiut University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Neurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy
- Status
- Not yet recruiting
- People taking part
- 75 people, planned
- Started
- Jan 2026
- Expected to end
- Feb 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- Nerve conduction study
- Nerve ultrasound
- Autonomic assessment
- Record updated
- 29 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 or type 2 diabetes, with or without nerve damage in the feet and legs (diabetic peripheral neuropathy). It also takes healthy people of similar age and sex for comparison.
- Age
- 18 to 75 years
- Sex
- All sexes
- Disease stage
- Type 1 or type 2 diabetes, with or without nerve damage. Healthy volunteers can also join.
Main reasons for not taking part
- Nerve damage from another cause, such as CIDP, injury, toxins or low vitamin levels
- Advanced kidney failure
- Thyroid disease or long-term heavy alcohol use
- Pregnancy
- An implanted heart device that may disturb the nerve tests
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Adults aged 18-75 years with type 1 or type 2 diabetes (with or without diabetic peripheral neuropathy), and age and sex-matched healthy controls
Who cannot take part
- Other causes of neuropathy (e.g., CIDP, trauma, toxins, vitamin deficiencies), advanced renal failure,thyroid disease,chronic alcohol use, pregnancy,
- presence of implanted cardiac devicesthat may interfere with autonomic testing
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Diabetic peripheral neuropathy causes pain, sensory loss, and foot risk; multimodal assessment enables earlier diagnosis and improved patient management.
The 3 groups in the trial
- Diabetic patients with symptomatic peripheral neuropathy.Other group
Treatment: Nerve conduction study and Nerve ultrasound
- Diabetic without any clinical features nor complaints of peripheral neuropathyOther group
Treatment: Nerve conduction study, Nerve ultrasound, and Autonomic assessment
- Healthy individuals.Other group
Treatment: Nerve conduction study, Nerve ultrasound, and Autonomic assessment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neurophysiological, Autonomic, and Sonographic Assessment of Diabetic Peripheral Neuropathy
- Plain-language title
- Nerve, autonomic and ultrasound checks for nerve damage in people with diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07306884, who can take part
- Record updated
- 29 December 2025